The tumor immune environment in advanced breast cancer following treatment with pembrolizumab and nab-paclitaxel

被引：0
|
作者：
Tyagi, Apoorvi
Voloshyna, Iryna
Klar, Natalie
Darvishian, Farbod
Hao, Yuan
Zhurova, Anastasia
Cynthia, Loomis
Marks, Douglas K.
Adams, Sylvia
Krogsgaard, Michelle
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2024年 / 212卷 / 01期
关键词：
D O I：
10.4049/jimmunol.212.supp.0730.7079
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
    Wan, Rui
    Guo, Yanrong
    Hao, Xuezhi
    Wang, Zhijie
    Duan, Jianchun
    Wang, Jie
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [32] Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel: Two Case Reports
    Araya, Tomoyuki
    Kita, Toshiyuki
    Matsuoka, Hiroki
    Sakai, Tamami
    Kimura, Hideharu
    Kasahara, Kazuo
    CASE REPORTS IN ONCOLOGY, 2020, 13 (03): : 1506 - 1512
  • [33] Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer
    Kokkali, Stefania
    Tripodaki, Elli-Sophia
    Drizou, Maria
    Stefanou, Dimitra
    Magou, Elpida
    Zylis, Dimosthenis
    Kapiris, Matthaios
    Nasi, Despoina
    Georganta, Chara
    Ardavanis, Alexandros
    IN VIVO, 2018, 32 (03): : 653 - 657
  • [34] QOL Evaluation of Nab-Paclitaxel and Docetaxel for Early Breast Cancer
    Okuyama, Hiromi
    Nakamura, Seigo
    Akashi-Tanaka, Sadako
    Sawada, Terumasa
    Kuwayama, Takashi
    Handa, Satoko
    Kato, Yasuhisa
    EUROPEAN JOURNAL OF BREAST HEALTH, 2018, 14 (04) : 194 - 198
  • [35] Nab-Paclitaxel Monotherapy as a Treatment of Patients with Metastatic Breast Cancer in Routine Clinical Practice
    Aigner, Julia
    Marme, Frederik
    Smetanay, Katharina
    Schuetz, Florian
    Jaeger, Dirk
    Schneeweiss, Andreas
    ANTICANCER RESEARCH, 2013, 33 (08) : 3407 - 3413
  • [36] Drug selection by Narrative approach in patients with advanced gastric cancer -Paclitaxel or nab-Paclitaxel?-
    Kawase, Tomono
    Imamura, Hiroshi
    Hirota, Masashi
    Nagase, Hirotsugu
    Noura, Shingo
    Tanida, Tsukasa
    Noguchi, Kouzou
    Ooshima, Kazuki
    Akagi, Kenzou
    Iwazawa, Takushi
    Douno, Keizou
    ANNALS OF ONCOLOGY, 2019, 30 : 99 - 99
  • [37] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Ueno, M.
    Kobayashi, S.
    Ohkawa, S.
    Tezuka, S.
    Moriya, S.
    Morimoto, M.
    ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
  • [38] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [39] MV Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma
    Unseld, Matthias
    Scheithauer, Werner
    Weigl, Roman
    Kornek, Gabriela
    Stranzl, Nadja
    Bianconi, Daniela
    Brunauer, Georg
    Steger, Guenther
    Zielinski, Christoph C.
    Prager, Gerald W.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 588 - 594
  • [40] Study on the intake and efficacy of nab-paclitaxel in patients with advanced cervical cancer
    Wang, Aihua
    Zhang, Feizhong
    Zhang, Xiaohua
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (04) : 95 - 101
12345